Map of Pancreatica Walks and Runs

Monthly Archives: December 2013

Salivary Fluid Markers for Cancer of the Pancreas: the Evidence Mounts

However counterintuitive, the association between saliva and the dental environment AND pancreatic cancer continues to garner highly interesting research.  One team lead by David T. Wong and colleagues at the Dental Research Institute of the UCLA School of Dentistry in Los Angeles, California first came to our attention per the Pancreatica blog on 6/23 of […]

Share Button

Prolonged Duration of Neoadjuvant Treatment May Confer Big Benefits in Cancer of the Pancreas

The move away from surgical diagnosis to radiographic criteria in many and now even most efforts at the staging of cancer of the pancreas carries a number of somewhat unspoken but profound consequences, one being efforts to find ways to downstage the diagnosis so as to profitably utilize surgery in locally advanced and borderline resectable […]

Share Button

Adjustments to the FOLFIRINOX Combination for Improved Tolerability in Pancreatic Cancer

Since the May 12, 2011 New England Journal of Medicine article that reported the possible superiority of the 5-FU based four-drug FOLFIRINOX regimen over gemcitabine in the treatment of metastatic pancreatic cancer (and subsequent FDA approval), researchers have been at work trying to discover the best use of this information – and ways to perhaps […]

Share Button